BFM
NUVB icon

Boothbay Fund Management’s Nuvation Bio NUVB Stock Holding History

Boothbay Fund Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-187,603
Closed -$366K – 2071
2025
Q2 		$366K Hold
187,603
– – 0.01% 1029
2025
Q1 		$330K Buy
187,603
+166,593
+793% +$379K 0.01% 1030
2024
Q4 		$55.9K Buy
21,010
+125
+0.6% +$322 ﹤0.01% 1345
2024
Q3 		$47.8K Sell
20,885
-68,964
-77% -$210K ﹤0.01% 1511
2024
Q2 		$262K Sell
89,849
-68,965
-43% -$210K 0.01% 1199
2024
Q1 		$578K Sell
158,814
-102,576
-39% -$197K 0.01% 955
2023
Q4 		$395K Hold
261,390
– – 0.01% 1085
2023
Q3 		$350K Buy
+261,390
New +$435K 0.01% 1192
2022
Q2 		– Sell
-22,640
Closed -$119K – 2543
2022
Q1 		$119K Hold
22,640
– – ﹤0.01% 2058
2021
Q4 		$192K Buy
+22,640
New +$208K ﹤0.01% 1504
2021
Q2 		– Sell
-49,635
Closed -$519K – 2029
2021
Q1 		$519K Buy
49,635
+28,147
+131% +$315K 0.02% 927
2020
Q4 		$251K Buy
+21,488
New +$223K 0.01% 1016

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Boothbay Fund Management's NUVB Position: Q3 2025 in Review

Boothbay Fund Management sold out of Nuvation Bio (NUVB) in Q3 2025, closing a stake of 187,603 shares — an estimated $366K sold.

Boothbay Fund Management first reported a position in NUVB in Q4 2020 and held it in 12 quarters. The position peaked at $578K in Q1 2024. 203 funds tracked by Wall St. Rank hold NUVB as of Q3 2025.

  • Boothbay Fund Management reported no remaining Nuvation Bio position as of Q3 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 187,603 Nuvation Bio shares in Q3 2025, an estimated $366K.
  • Boothbay Fund Management first reported a position in Nuvation Bio in Q4 2020 and held it in 12 quarters.
  • Boothbay Fund Management's Nuvation Bio position peaked at $578K in Q1 2024.
  • 203 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2025.

Based on Boothbay Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.